N-[5-(4-fluorophenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-2-naphthalen-2-ylacetamide;N-[5-(4-fluorophenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-2-phenylacetamide;N-[5-(4-fluorophenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-4-phenylbutanamide;N-[5-(4-fluorophenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-3-phenylpropanamide

C111H88F4N12O4 — CID 160783148

IUPACN-[5-(4-fluorophenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-2-naphthalen-2-ylacetamide;N-[5-(4-fluorophenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-2-phenylacetamide;N-[5-(4-fluorophenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-4-phenylbutanamide;N-[5-(4-fluorophenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-3-phenylpropanamide
SMILESO=C(CCCc1ccccc1)Nc1ncc(-c2ccc(F)cc2)nc1/C=C/c1ccccc1.O=C(CCc1ccccc1)Nc1ncc(-c2ccc(F)cc2)nc1/C=C/c1ccccc1.O=C(Cc1ccc2ccccc2c1)Nc1ncc(-c2ccc(F)cc2)nc1/C=C/c1ccccc1.O=C(Cc1ccccc1)Nc1ncc(-c2ccc(F)cc2)nc1/C=C/c1ccccc1
InChIInChI=1S/C30H22FN3O.C28H24FN3O.C27H22FN3O.C26H20FN3O/c31-26-15-13-24(14-16-26)28-20-32-30(27(33-28)17-11-21-6-2-1-3-7-21)34-29(35)19-22-10-12-23-8-4-5-9-25(23)18-22;29-24-17-15-23(16-18-24)26-20-30-28(25(31-26)19-14-22-10-5-2-6-11-22)32-27(33)13-7-12-21-8-3-1-4-9-21;28-23-15-13-22(14-16-23)25-19-29-27(24(30-25)17-11-20-7-3-1-4-8-20)31-26(32)18-12-21-9-5-2-6-10-21;27-22-14-12-21(13-15-22)24-18-28-26(30-25(31)17-20-9-5-2-6-10-20)23(29-24)16-11-19-7-3-1-4-8-19/h1-18,20H,19H2,(H,32,34,35);1-6,8-11,14-20H,7,12-13H2,(H,30,32,33);1-11,13-17,19H,12,18H2,(H,29,31,32);1-16,18H,17H2,(H,28,30,31)/b17-11+;19-14+;17-11+;16-11+
InChIKeySAVRVETUCQYDJW-KXHRFNPISA-N
MW1730.00 g/mol
LogP24.86
Rot. Bonds27

About N-[5-(4-fluorophenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-2-naphthalen-2-ylacetamide;N-[5-(4-fluorophenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-2-phenylacetamide;N-[5-(4-fluorophenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-4-phenylbutanamide;N-[5-(4-fluorophenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-3-phenylpropanamide

N-[5-(4-fluorophenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-2-naphthalen-2-ylacetamide;N-[5-(4-fluorophenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-2-phenylacetamide;N-[5-(4-fluorophenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-4-phenylbutanamide;N-[5-(4-fluorophenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-3-phenylpropanamide (PubChem CID 160783148) has the molecular formula C111H88F4N12O4 and a molecular weight of 1730.00 g/mol. Its IUPAC name is N-[5-(4-fluorophenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-2-naphthalen-2-ylacetamide;N-[5-(4-fluorophenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-2-phenylacetamide;N-[5-(4-fluorophenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-4-phenylbutanamide;N-[5-(4-fluorophenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-3-phenylpropanamide.

Molecular Properties

Compound NameN-[5-(4-fluorophenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-2-naphthalen-2-ylacetamide;N-[5-(4-fluorophenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-2-phenylacetamide;N-[5-(4-fluorophenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-4-phenylbutanamide;N-[5-(4-fluorophenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-3-phenylpropanamide
PubChem CID160783148
Molecular FormulaC111H88F4N12O4
Molecular Weight1730.00 g/mol
Exact Mass1728.70
IUPAC NameN-[5-(4-fluorophenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-2-naphthalen-2-ylacetamide;N-[5-(4-fluorophenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-2-phenylacetamide;N-[5-(4-fluorophenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-4-phenylbutanamide;N-[5-(4-fluorophenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-3-phenylpropanamide
SMILESO=C(CCCc1ccccc1)Nc1ncc(-c2ccc(F)cc2)nc1/C=C/c1ccccc1.O=C(CCc1ccccc1)Nc1ncc(-c2ccc(F)cc2)nc1/C=C/c1ccccc1.O=C(Cc1ccc2ccccc2c1)Nc1ncc(-c2ccc(F)cc2)nc1/C=C/c1ccccc1.O=C(Cc1ccccc1)Nc1ncc(-c2ccc(F)cc2)nc1/C=C/c1ccccc1
InChIInChI=1S/C30H22FN3O.C28H24FN3O.C27H22FN3O.C26H20FN3O/c31-26-15-13-24(14-16-26)28-20-32-30(27(33-28)17-11-21-6-2-1-3-7-21)34-29(35)19-22-10-12-23-8-4-5-9-25(23)18-22;29-24-17-15-23(16-18-24)26-20-30-28(25(31-26)19-14-22-10-5-2-6-11-22)32-27(33)13-7-12-21-8-3-1-4-9-21;28-23-15-13-22(14-16-23)25-19-29-27(24(30-25)17-11-20-7-3-1-4-8-20)31-26(32)18-12-21-9-5-2-6-10-21;27-22-14-12-21(13-15-22)24-18-28-26(30-25(31)17-20-9-5-2-6-10-20)23(29-24)16-11-19-7-3-1-4-8-19/h1-18,20H,19H2,(H,32,34,35);1-6,8-11,14-20H,7,12-13H2,(H,30,32,33);1-11,13-17,19H,12,18H2,(H,29,31,32);1-16,18H,17H2,(H,28,30,31)/b17-11+;19-14+;17-11+;16-11+
InChIKeySAVRVETUCQYDJW-KXHRFNPISA-N
XLogP24.86
TPSA219.52 Ų
H-Bond Donors4
H-Bond Acceptors12
Rotatable Bonds27
Heavy Atoms131
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001730.00
LogP ≤ 524.86
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1012

Analyze N-[5-(4-fluorophenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-2-naphthalen-2-ylacetamide;N-[5-(4-fluorophenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-2-phenylacetamide;N-[5-(4-fluorophenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-4-phenylbutanamide;N-[5-(4-fluorophenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-3-phenylpropanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

N-[5-(4-aminophenyl)-3-(2-phenylethenyl)pyrazin-2-yl]-2-naphthalen-2-ylacetamide
CID 77496997
2-phenyl-N-[5-phenyl-3-(2-phenylethenyl)pyrazin-2-yl]acetamide
CID 77496875
N-[5-(4-fluorophenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-2-(2,3,4,5,6-pentafluorophenyl)acetamide
CID 140639355
2-(4-hydroxyphenyl)-N-[5-(4-hydroxyphenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]acetamide
CID 135980268
N-[5-(4-aminophenyl)-3-(2-phenylethenyl)pyrazin-2-yl]-2-phenylacetamide
CID 77497000
N-[5-(4-hydroxyphenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-2-(4-iodophenyl)acetamide
CID 136625436
N-[5-(4-aminophenyl)-3-(2-cyclohexylethyl)pyrazin-2-yl]-2-naphthalen-2-ylacetamide;N-[5-(4-aminophenyl)-3-(2-cyclohexylethyl)pyrazin-2-yl]-2-phenylacetamide;N-[5-(4-aminophenyl)-3-(2-cyclohexylethyl)pyrazin-2-yl]-4-phenylbutanamide;N-[5-(4-aminophenyl)-3-(2-cyclohexylethyl)pyrazin-2-yl]-3-phenylpropanamide
CID 159051784
2-(2,3,4,5,6-pentafluorophenyl)-N-[5-phenyl-3-[(E)-2-phenylethenyl]pyrazin-2-yl]acetamide
CID 140639364
2-(4-bromophenyl)-N-[5-[4-(hydroxymethyl)phenyl]-3-[(E)-2-phenylethenyl]pyrazin-2-yl]acetamide;2-(4-chlorophenyl)-N-[5-[4-(hydroxymethyl)phenyl]-3-[(E)-2-phenylethenyl]pyrazin-2-yl]acetamide;2-(4-fluorophenyl)-N-[5-[4-(hydroxymethyl)phenyl]-3-[(E)-2-phenylethenyl]pyrazin-2-yl]acetamide;N-[5-[4-(hydroxymethyl)phenyl]-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-2-(4-hydroxyphenyl)acetamide
CID 161312011
N-[5-(4-aminophenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-2-(4-bromophenyl)acetamide;N-[5-(4-aminophenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-2-(4-chlorophenyl)acetamide;N-[5-(4-aminophenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-2-(4-fluorophenyl)acetamide;N-[5-(4-aminophenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-2-(4-hydroxyphenyl)acetamide
CID 159315155
2-cyclohexyl-N-(3,5-diphenylpyrazin-2-yl)acetamide;N-(3,5-diphenylpyrazin-2-yl)acetamide;N-(3,5-diphenylpyrazin-2-yl)benzamide;N-(3,5-diphenylpyrazin-2-yl)-2-naphthalen-2-ylacetamide;N-(3,5-diphenylpyrazin-2-yl)-2-phenylacetamide;N-(3,5-diphenylpyrazin-2-yl)-4-phenylbutanamide;N-(3,5-diphenylpyrazin-2-yl)-3-phenylpropanamide
CID 159829946
N-[5-[4-(hydroxymethyl)phenyl]-3-(2-phenylethenyl)pyrazin-2-yl]benzamide
CID 123669034

Frequently Asked Questions

What is the IUPAC name of N-[5-(4-fluorophenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-2-naphthalen-2-ylacetamide;N-[5-(4-fluorophenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-2-phenylacetamide;N-[5-(4-fluorophenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-4-phenylbutanamide;N-[5-(4-fluorophenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-3-phenylpropanamide?
The IUPAC name of N-[5-(4-fluorophenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-2-naphthalen-2-ylacetamide;N-[5-(4-fluorophenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-2-phenylacetamide;N-[5-(4-fluorophenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-4-phenylbutanamide;N-[5-(4-fluorophenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-3-phenylpropanamide (CID 160783148) is N-[5-(4-fluorophenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-2-naphthalen-2-ylacetamide;N-[5-(4-fluorophenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-2-phenylacetamide;N-[5-(4-fluorophenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-4-phenylbutanamide;N-[5-(4-fluorophenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-3-phenylpropanamide.
What is the SMILES notation for N-[5-(4-fluorophenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-2-naphthalen-2-ylacetamide;N-[5-(4-fluorophenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-2-phenylacetamide;N-[5-(4-fluorophenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-4-phenylbutanamide;N-[5-(4-fluorophenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-3-phenylpropanamide?
The canonical SMILES for N-[5-(4-fluorophenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-2-naphthalen-2-ylacetamide;N-[5-(4-fluorophenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-2-phenylacetamide;N-[5-(4-fluorophenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-4-phenylbutanamide;N-[5-(4-fluorophenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-3-phenylpropanamide is O=C(CCCc1ccccc1)Nc1ncc(-c2ccc(F)cc2)nc1/C=C/c1ccccc1.O=C(CCc1ccccc1)Nc1ncc(-c2ccc(F)cc2)nc1/C=C/c1ccccc1.O=C(Cc1ccc2ccccc2c1)Nc1ncc(-c2ccc(F)cc2)nc1/C=C/c1ccccc1.O=C(Cc1ccccc1)Nc1ncc(-c2ccc(F)cc2)nc1/C=C/c1ccccc1.
What is the InChIKey of N-[5-(4-fluorophenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-2-naphthalen-2-ylacetamide;N-[5-(4-fluorophenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-2-phenylacetamide;N-[5-(4-fluorophenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-4-phenylbutanamide;N-[5-(4-fluorophenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-3-phenylpropanamide?
The InChIKey is SAVRVETUCQYDJW-KXHRFNPISA-N. The full InChI is InChI=1S/C30H22FN3O.C28H24FN3O.C27H22FN3O.C26H20FN3O/c31-26-15-13-24(14-16-26)28-20-32-30(27(33-28)17-11-21-6-2-1-3-7-21)34-29(35)19-22-10-12-23-8-4-5-9-25(23)18-22;29-24-17-15-23(16-18-24)26-20-30-28(25(31-26)19-14-22-10-5-2-6-11-22)32-27(33)13-7-12-21-8-3-1-4-9-21;28-23-15-13-22(14-16-23)25-19-29-27(24(30-25)17-11-20-7-3-1-4-8-20)31-26(32)18-12-21-9-5-2-6-10-21;27-22-14-12-21(13-15-22)24-18-28-26(30-25(31)17-20-9-5-2-6-10-20)23(29-24)16-11-19-7-3-1-4-8-19/h1-18,20H,19H2,(H,32,34,35);1-6,8-11,14-20H,7,12-13H2,(H,30,32,33);1-11,13-17,19H,12,18H2,(H,29,31,32);1-16,18H,17H2,(H,28,30,31)/b17-11+;19-14+;17-11+;16-11+.
What are the key properties of N-[5-(4-fluorophenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-2-naphthalen-2-ylacetamide;N-[5-(4-fluorophenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-2-phenylacetamide;N-[5-(4-fluorophenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-4-phenylbutanamide;N-[5-(4-fluorophenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-3-phenylpropanamide?
N-[5-(4-fluorophenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-2-naphthalen-2-ylacetamide;N-[5-(4-fluorophenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-2-phenylacetamide;N-[5-(4-fluorophenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-4-phenylbutanamide;N-[5-(4-fluorophenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-3-phenylpropanamide has a molecular weight of 1730.00 g/mol, XLogP of 24.86, 27 rotatable bonds, 4 hydrogen bond donors, and 12 hydrogen bond acceptors.
Where does this data come from?
All data for N-[5-(4-fluorophenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-2-naphthalen-2-ylacetamide;N-[5-(4-fluorophenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-2-phenylacetamide;N-[5-(4-fluorophenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-4-phenylbutanamide;N-[5-(4-fluorophenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-3-phenylpropanamide is sourced from PubChem (CID 160783148), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).